A panel of medical ethicists convened by World Health Organisation, WHO, said in Geneva on Tuesday that the use of experimental-stage Ebola drugs was justified.
The panel reached consensus that it was ethical to offer unproven interventions with as yet unknown efficacy and adverse effects, as potential treatment or prevention, in the particular circumstances of the outbreak.
The experts, however, noted that these interventions could only be provided if certain conditions were met.
They stressed that patients must be able to make a free and well-informed choice whether they want to receive non-licensed drugs. They advised that the data on treated patients must be collected and shared to learn more about the effectiveness and safety of the drugs.
The U.S. President, Barack Obama, recently said his government would not make available to African countries the experimental drug tested on two American doctors that contacted Ebola while in West Africa. The drug is believed to have helped the doctors recover.
Mr. Obama said the drug would not be released until certified fit for human use by experts.
Support PREMIUM TIMES' journalism of integrity and credibility
Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.
By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.
TEXT AD: To advertise here . Call Willie +2347088095401...